Screener
Neuropace, Inc. NPCE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s total equity?
- Neuropace, Inc. (NPCE) reported total equity of $11.88M in Q2 2026.
- How has Neuropace, Inc.'s total equity changed year-over-year?
- Neuropace, Inc.'s total equity decreased by 38.9% year-over-year, from $19.44M to $11.88M.
- What is the long-term trend for Neuropace, Inc.'s total equity?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s total equity has grown at a -33.6% compound annual growth rate (CAGR), from -$147.83M to $19.03M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Neuropace, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude